Children’s version of COVID vaccination calculator released While vaccine coverage for 5–11-year-olds remains low, the updated CoRiCal tool could help boost uptake among the cohort.
ATAGI gives Moderna bivalent vaccine green light There will soon be two bivalent vaccines available to people aged 12 and over.
Updating COVID-19 vaccines ‘on the agenda’, but not sustainable Many Australians were recently recommended a fifth dose – but vaccination fatigue has researchers looking for longer term solutions.
Second bivalent booster receives ATAGI recommendation The vaccine will become available in December and is recommended for people who have not had their first or second booster doses.
What do bivalent vaccines mean for Australia’s rollout? The first doses of Moderna’s variant-specific COVID vaccine became available this week, offering a slight advantage over previous versions.
Confusion as Government walks back bivalent dose commitment Australia will not receive 15 million doses of variant-specific vaccines from Moderna in 2022.
TGA approves second COVID-19 vaccine for youngest children The Pfizer vaccine is now approved for use in children aged six months to five years, with Moderna already available to the age group.
Independent review into COVID vaccine procurement released Eight recommendations have been handed down, with the next two years identified as ‘critical’ to Australia’s recovery.
Government confirms bivalent vaccine supply Moderna will deliver 15 million doses of its new Omicron-specific vaccine by the end of the year, with doses set to become available next month.
Vaccine rollout ‘relied on GP goodwill’: Study General practices involved in Australia’s COVID-19 vaccination program struggled to make ends meet, researchers say.